Drug Shortage Report for NITOMAN
Report ID | 159533 |
Drug Identification Number | 02199270 |
Brand name | NITOMAN |
Common or Proper name | NITOMAN |
Company Name | BAUSCH HEALTH, CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | TETRABENAZINE |
Strength(s) | 25MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | N/A |
ATC code | N07XX |
ATC description | OTHER NERVOUS SYSTEM DRUGS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2022-04-21 |
Estimated end date | 2022-05-26 |
Actual end date | 2022-05-17 |
Shortage status | Resolved |
Updated date | 2022-05-26 |
Company comments | awaiting documents from supplier |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2022-05-26 | French | Compare |
v3 | 2022-05-26 | English | Compare |
v2 | 2022-04-28 | French | Compare |
v1 | 2022-04-28 | English | Compare |
Showing 1 to 4 of 4